Celularity (CELUW) Other Non-Current Liabilities (2019 - 2025)
Celularity (CELUW) reported Other Non-Current Liabilities of $1.5 million for Q4 2025, down 52.67% year-over-year from $3.3 million in Q4 2024, and down 56.16% quarter-over-quarter from $3.5 million in Q3 2025.
Celularity (CELUW) Other Non-Current Liabilities (2019 - 2025) Analysis & Trends
Celularity (CELUW) has 7 years of Other Non-Current Liabilities data on file, last reported at $1.5 million in Q4 2025.
- Other Non-Current Liabilities for Q4 2025 came in at $1.5 million, down 52.67% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.5 million (down 52.67% YoY), and the FY2025 annual result was $1.5 million, down 52.67% from the prior year.
- Other Non-Current Liabilities retreated to $1.5 million in Q4 2025 per CELUW's latest filing, from $3.5 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $255.5 million in Q3 2021 and troughed at $283000.0 in Q3 2024.
- A 5-year average of $36.9 million and a median of $8.1 million in 2024 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Liabilities plunged 99.72% in 2023, then soared 4645.91% in 2024.
- A 5-year view of Other Non-Current Liabilities shows it stood at $232.2 million in 2021, then sank by 54.38% to $105.9 million in 2022, then sank by 99.72% to $294000.0 in 2023, then soared by 1010.2% to $3.3 million in 2024, then sank by 52.67% to $1.5 million in 2025.
- Business Quant data shows CELUW's Other Non-Current Liabilities at $1.5 million in Q4 2025, $3.5 million in Q3 2025, and $8.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Celularity | - | - | -3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.55 Mn |
| Sep 30, 2025 | 3.52 Mn |
| Jun 30, 2025 | 8.78 Mn |
| Mar 31, 2025 | 8.07 Mn |
| Dec 31, 2024 | 3.26 Mn |
| Sep 30, 2024 | 283,000.00 |
| Jun 30, 2024 | 8.09 Mn |
| Mar 31, 2024 | 15.09 Mn |
| Dec 31, 2023 | 294,000.00 |
| Sep 30, 2023 | 1.61 Mn |
| Jun 30, 2023 | 1.61 Mn |
| Mar 31, 2023 | 318,000.00 |
| Dec 31, 2022 | 105.95 Mn |
| Sep 30, 2022 | 14.09 Mn |
| Jun 30, 2022 | 23.43 Mn |
| Mar 31, 2022 | 1.90 Mn |
| Dec 31, 2021 | 232.22 Mn |
| Sep 30, 2021 | 255.52 Mn |
| Jun 30, 2021 | 29.35 Mn |
| Mar 31, 2021 | 23.79 Mn |